{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T19:40:38Z","timestamp":1776973238728,"version":"3.51.4"},"reference-count":41,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"16","license":[{"start":{"date-parts":[[2025,4,18]],"date-time":"2025-04-18T00:00:00Z","timestamp":1744934400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,4,18]]},"abstract":"<jats:p>Stable angina pectoris (SAP) is a prevalent manifestation of ischemic heart disease, characterized by chest pain due to myocardial ischemia. Although standard pharmacological treatments such as nitrates, beta-blockers, and calcium channel blockers are commonly prescribed, their long-term efficacy is often limited by side effects, prompting interest in alternative therapies. Compound Danshen droplet Pills (CDDP), a traditional Chinese medicine formulation comprising Salvia miltiorrhiza, Panax notoginseng, and Borneol, has been widely used in China for its cardiovascular benefits, including improving circulation and alleviating angina symptoms. Despite its clinical use, systematic evaluations of CDDP\u2019s efficacy in SAP management are limited. This review summarizes the clinical evidence on CDDP for SAP treatment by analyzing randomized controlled trials (RCTs). A comprehensive search of the China National Knowledge Infrastructure and PubMed databases was conducted, covering studies up to July 31, 2024, using terms such as \u201ccompound Danshen droplet pills\u201d and \u201cstable angina pectoris.\u201d Only peer-reviewed RCTs focusing on CDDP for SAP, published in English or Chinese, were included. After a rigorous screening process by 2 independent authors, with discrepancies resolved by a third, 10 eligible RCTs were selected for review. The results suggest that CDDP may provide significant therapeutic benefits, including anti-ischemic, vasodilatory, and antioxidative effects, with favorable safety profiles in both monotherapy and combination therapy. However, further multicenter RCTs are necessary to validate its long-term efficacy and safety. This review highlights the potential of CDDP as a complementary therapy for SAP and underscores the need for further evidence-based research to optimize its clinical use.<\/jats:p>","DOI":"10.1097\/md.0000000000042175","type":"journal-article","created":{"date-parts":[[2025,5,6]],"date-time":"2025-05-06T11:00:38Z","timestamp":1746529238000},"page":"e42175","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":5,"title":["Advances of clinical trials on compound Danshen dripping pills for stable angina pectoris: A perspective"],"prefix":"10.1097","volume":"104","author":[{"given":"Xiao-feng","family":"Liu","sequence":"first","affiliation":[{"name":"Department of Chinese Medicine Pharmacy, Shengzhou People\u2019s Hospital (Shengzhou Branch of the First Affiliated Hospital of Zhejiang University School of Medicine), Shengzhou, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-6978-3883","authenticated-orcid":false,"given":"Xiao-xiao","family":"Zhu","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Shengzhou People\u2019s Hospital (Shengzhou Branch of the First Affiliated Hospital of Zhejiang University School of Medicine), Shengzhou, China."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20250904","doi-asserted-by":"crossref","first-page":"2264","DOI":"10.1016\/j.jacc.2007.08.002","article-title":"2007 chronic angina focused update of the ACC\/AHA 2002 guidelines for the management of patients with chronic stable angina: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines Writing Group to Develop the Focused Update of the 2002 Guidelines for the Management of Patients With Chronic Stable Angina.","volume":"50","author":"Fraker","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"R2-20250904","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1093\/eurheartj\/ehz425","article-title":"2019 ESC guidelines for the diagnosis and management of chronic coronary syndromes.","volume":"41","author":"Knuuti","year":"2020","journal-title":"Eur Heart J"},{"key":"R3-20250904","doi-asserted-by":"crossref","first-page":"e56","DOI":"10.1161\/CIR.0000000000000659","article-title":"Heart disease and stroke statistics-2019 update: a report from the American Heart Association.","volume":"139","author":"Benjamin","year":"2019","journal-title":"Circulation"},{"key":"R4-20250904","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1001\/jama.2012.12559","article-title":"\u03b2-Blocker use and clinical outcomes in stable outpatients with and without coronary artery disease.","volume":"308","author":"Bangalore","year":"2012","journal-title":"JAMA"},{"key":"R5-20250904","doi-asserted-by":"crossref","first-page":"4189","DOI":"10.1007\/s12325-022-02222-1","article-title":"Efficacy and safety of ivabradine in combination with beta-blockers in patients with stable angina pectoris: a systematic review and meta-analysis.","volume":"39","author":"Nedoshivin","year":"2022","journal-title":"Adv Ther"},{"key":"R6-20250904","first-page":"1357","article-title":"Systematic review on the short-term efficacy and safety of nicorandil for stable angina pectoris in comparison with those of beta-blockers, nitrates and calcium antagonists.","volume":"60","author":"Gilarevskii","year":"2020","journal-title":"Kardiologiia"},{"key":"R7-20250904","first-page":"708","article-title":"Progress in quality control and pharmacological research of compound danshen dripping pills.","volume":"9","author":"Xiang","year":"2007","journal-title":"Chin Pharm"},{"key":"R8-20250904","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1177\/0091270005282630","article-title":"Danshen: an overview of its chemistry, pharmacology, pharmacokinetics, and clinical use.","volume":"45","author":"Zhou","year":"2005","journal-title":"J Clin Pharmacol"},{"key":"R9-20250904","doi-asserted-by":"crossref","first-page":"3481","DOI":"10.1161\/CIRCULATIONAHA.105.537878","article-title":"Pathophysiology of coronary artery disease.","volume":"111","author":"Libby","year":"2005","journal-title":"Circulation"},{"key":"R10-20250904","doi-asserted-by":"crossref","first-page":"2004","DOI":"10.1056\/NEJMra1216063","article-title":"Mechanisms of acute coronary syndromes and their implications for therapy.","volume":"368","author":"Libby","year":"2013","journal-title":"N Engl J Med"},{"key":"R11-20250904","doi-asserted-by":"crossref","first-page":"e44","DOI":"10.1016\/j.jacc.2012.07.013","article-title":"2012 ACCF\/AHA\/ACP\/AATS\/PCNA\/ SCAI\/STS guideline for the diagnosis and management of patients with stable ischemic heart disease: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines, and the American College of Physicians, American Association for Thoracic Surgery, Preventive Cardiovascular Nurses Association, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons.","volume":"60","author":"Fihn","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"R12-20250904","first-page":"837","article-title":"Canadian cardiovascular society guidelines for the diagnosis and management of stable ischemic heart disease.","volume":"30","author":"Mancini","year":"2014","journal-title":"Can J Cardiol"},{"key":"R13-20250904","doi-asserted-by":"crossref","first-page":"587","DOI":"10.2337\/dc07-1030","article-title":"Prevalence of the metabolic syndrome among U.S. adolescents using the definition from the International Diabetes Federation.","volume":"31","author":"Ford","year":"2008","journal-title":"Diabetes Care"},{"key":"R14-20250904","doi-asserted-by":"crossref","first-page":"e5311","DOI":"10.1002\/bmc.5311","article-title":"Enhancing effect of borneol on pharmacokinetics of ginsenoside Rb(1), ginsenoside Rg(1), and notoginsenoside R(1) in healthy volunteers after oral administration of compound danshen dropping pills.","volume":"36","author":"Zheng","year":"2022","journal-title":"Biomed Chromatogr"},{"key":"R15-20250904","doi-asserted-by":"crossref","first-page":"9541","DOI":"10.1038\/s41598-021-89035-4","article-title":"Elucidating direct kinase targets of compound danshen dropping pills employing archived data and prediction models.","volume":"11","author":"Wang","year":"2021","journal-title":"Sci Rep"},{"key":"R16-20250904","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1002\/med.20077","article-title":"New developments in the chemistry and biology of the bioactive constituents of Tanshen.","volume":"27","author":"Wang","year":"2007","journal-title":"Med Res Rev"},{"key":"R17-20250904","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.jep.2016.05.005","article-title":"Traditional uses, botany, phytochemistry, pharmacology, pharmacokinetics and toxicology of Panax notoginseng (Burk.) F.H. Chen: a review.","volume":"188","author":"Wang","year":"2016","journal-title":"J Ethnopharmacol"},{"key":"R18-20250904","doi-asserted-by":"crossref","first-page":"204840","DOI":"10.1155\/2014\/204840","article-title":"Protective effects of Panax notoginseng saponins on cardiovascular diseases: a comprehensive overview of experimental studies.","volume":"2014","author":"Yang","year":"2014","journal-title":"Evid Based Complement Alternat Med"},{"key":"R19-20250904","doi-asserted-by":"crossref","first-page":"105627","DOI":"10.1016\/j.phrs.2021.105627","article-title":"Borneol in cardio-cerebrovascular diseases: pharmacological actions, mechanisms, and therapeutics.","volume":"169","author":"Liu","year":"2021","journal-title":"Pharmacol Res"},{"key":"R20-20250904","first-page":"265","article-title":"Comparative study of the pharmacokinetics of borneolum syntheticum and borneol in herbal preparations.","volume":"17","author":"Huang","year":"2006","journal-title":"Tradit Chin Drug Res Clin Pharmacol"},{"key":"R21-20250904","first-page":"63","article-title":"Clinical observation of compound danshen dripping pills in the treatment of stable angina pectoris.","volume":"33","author":"Wang","year":"2021","journal-title":"Tianjin Pharm"},{"key":"R22-20250904","first-page":"148","article-title":"Effect of compound danshen dripping pills on stable angina pectoris with qi stagnation and blood stasis syndrome and its influence on serum ET-1, NO, and hs-CRP levels.","volume":"5","author":"Li","year":"2020","journal-title":"Clin Med Res Pract"},{"key":"R23-20250904","first-page":"144","article-title":"Clinical efficacy evaluation of compound danshen dripping pills in the treatment of stable angina pectoris.","volume":"11","author":"Zhou","year":"2019","journal-title":"Chin Contin Med Educ"},{"key":"R24-20250904","first-page":"44","article-title":"Analysis of the effect of compound danshen dripping pills in treating chronic stable angina pectoris with blood stasis syndrome.","volume":"47","author":"Zhang","year":"2018","journal-title":"Heilongjiang Tradit Chin Med"},{"key":"R25-20250904","first-page":"2043","article-title":"Observation of the efficacy of compound danshen dripping pills in stable angina pectoris and its impact on CRP and BNP.","volume":"12","author":"Wang","year":"2017","journal-title":"World Chin Med"},{"key":"R26-20250904","first-page":"1934","article-title":"Analysis of the effect of compound danshen dripping pills in the treatment of stable coronary heart disease angina.","volume":"27","author":"Zhao","year":"2016","journal-title":"Modern Diagn Treat"},{"key":"R27-20250904","first-page":"106","article-title":"Efficacy analysis of using compound danshen dripping pills in the treatment of stable angina pectoris.","volume":"14","author":"Zhang","year":"2016","journal-title":"Contemp Med Forum"},{"key":"R28-20250904","first-page":"18","article-title":"Clinical observation of compound danshen dripping pills combined with isosorbide dinitrate tablets in the treatment of stable angina pectoris: a study of 100 cases.","volume":"27","author":"Jiang","year":"2011","journal-title":"Chin Comm Doc"},{"key":"R29-20250904","first-page":"191","article-title":"Clinical observation of compound danshen dripping pills combined with isosorbide dinitrate tablets in the treatment of stable angina pectoris: a study of 112 cases.","volume":"6","author":"Cao","year":"2011","journal-title":"Chin Pract Med"},{"key":"R30-20250904","first-page":"113+116","article-title":"Clinical observation of compound danshen dripping pills combined with isosorbide dinitrate tablets in the treatment of stable angina pectoris: a study of 100 cases.","volume":"16","author":"Jiang","year":"2009","journal-title":"Chin Mod Med"},{"key":"R31-20250904","first-page":"591","article-title":"The efficacy and safety of compound danshen dripping pills combined with conventional treatment for angina pectoris: a systematic review and meta-analysis.","volume":"11","author":"Li","year":"2020","journal-title":"Front Pharmacol"},{"key":"R32-20250904","doi-asserted-by":"crossref","first-page":"1168730","DOI":"10.3389\/fcvm.2023.1168730","article-title":"Compound danshen dripping pills vs. nitrates for stable angina pectoris: a systematic review and meta-analysis.","volume":"10","author":"Zhang","year":"2023","journal-title":"Front Cardiovasc Med"},{"key":"R33-20250904","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1007\/s12012-022-09760-8","article-title":"Salvianolic acid B alleviates myocardial ischemia injury by suppressing NLRP3 inflammasome activation via SIRT1-AMPK-PGC-1\u03b1 signaling pathway.","volume":"22","author":"Li","year":"2022","journal-title":"Cardiovasc Toxicol"},{"key":"R34-20250904","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1038\/s41440-018-0139-9","article-title":"Mechanisms of action of Panax notoginseng ethanolic extract for its vasodilatory effects and partial characterization of vasoactive compounds.","volume":"42","author":"Loh","year":"2019","journal-title":"Hypertens Res"},{"key":"R35-20250904","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/1749-8546-6-37","article-title":"Comparative study on saponin fractions from Panax notoginseng inhibiting inflammation-induced endothelial adhesion molecule expression and monocyte adhesion.","volume":"6","author":"Wang","year":"2011","journal-title":"Chin Med"},{"key":"R36-20250904","doi-asserted-by":"crossref","first-page":"26942","DOI":"10.1021\/acsomega.1c03282","article-title":"Mechanisms and molecular targets of compound danshen dropping pill for heart disease caused by high altitude based on network pharmacology and molecular docking.","volume":"6","author":"Yan","year":"2021","journal-title":"ACS Omega"},{"key":"R37-20250904","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1080\/13880209.2021.1998139","article-title":"Compound danshen dripping pill inhibits high altitude-induced hypoxic damage by suppressing oxidative stress and inflammatory responses.","volume":"59","author":"Hu","year":"2021","journal-title":"Pharm Biol"},{"key":"R38-20250904","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1007\/s12192-019-01027-6","article-title":"Tanshinone IIA attenuates cardiac microvascular ischemia-reperfusion injury via regulating the SIRT1-PGC1\u03b1-mitochondrial apoptosis pathway.","volume":"24","author":"Zhong","year":"2019","journal-title":"Cell Stress Chaperones"},{"key":"R39-20250904","doi-asserted-by":"crossref","first-page":"37919","DOI":"10.1038\/srep37919","article-title":"Compound danshen dripping pills modulate the perturbed energy metabolism in a rat model of acute myocardial ischemia.","volume":"6","author":"Guo","year":"2016","journal-title":"Sci Rep"},{"key":"R40-20250904","doi-asserted-by":"crossref","first-page":"718305","DOI":"10.1155\/2013\/718305","article-title":"Metabonomic strategy to the evaluation of Chinese medicine compound danshen dripping pills interfering myocardial ischemia in rats.","volume":"2013","author":"Xin","year":"2013","journal-title":"Evid Based Complement Alternat Med"},{"key":"R41-20250904","first-page":"123","article-title":"The effects of compound danshen dripping pills and human umbilical cord blood mononuclear cell transplant after acute myocardial infarction.","volume":"12","author":"Yi","year":"2014","journal-title":"Exp Clin Transplant"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000042175","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,4]],"date-time":"2025-09-04T12:01:24Z","timestamp":1756987284000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000042175"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,18]]},"references-count":41,"journal-issue":{"issue":"16","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000042175","relation":{},"ISSN":["1536-5964"],"issn-type":[{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,18]]}}}